tiprankstipranks
InnoCan Pharma (TSE:INNO)
CNQX:INNO
Holding TSE:INNO?
Track your performance easily

InnoCan Pharma (INNO) Financial Statements

11 Followers

InnoCan Pharma Financial Overview

InnoCan Pharma's market cap is currently ―. The company's EPS TTM is C$-0.013; its P/E ratio is -16.03; InnoCan Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 8.62M$ 8.64M$ 6.77M$ 4.89M$ 4.08M
Gross Profit$ 7.78M$ 8.00M$ 6.00M$ 4.29M$ 3.66M
EBIT$ 704.00K$ 1.55M$ -1.17M$ -588.00K$ -1.82M
EBITDA$ 713.00K$ 1.56M$ -1.16M$ -580.00K$ -1.81M
Net Income Common Stockholders$ -290.00K$ 455.00K$ -1.77M$ -883.00K$ -2.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.06M$ 5.19M$ 4.59M$ 3.88M$ 4.02M
Total Assets$ 9.60M$ 8.72M$ 9.04M$ 6.94M$ 6.87M
Total Debt$ 1.00K$ 4.00K$ 7.00K$ 33.00K$ 16.00K
Net Debt$ -5.06M$ -5.18M$ -4.59M$ -3.85M$ -4.01M
Total Liabilities$ 2.65M$ 2.67M$ 4.33M$ 2.55M$ 2.37M
Stockholders Equity$ 5.15M$ 4.83M$ 4.11M$ 4.10M$ 4.30M
Cash Flow-
Free Cash Flow$ -1.01M$ 672.00K$ -749.00K$ -1.32M$ -719.00K
Operating Cash Flow$ -1.00M$ 675.00K$ -747.00K$ -1.31M$ -1.88M
Investing Cash Flow$ -6.00K$ -3.00K$ -2.00K$ -9.00K$ -66.00K
Financing Cash Flow$ 859.00K$ -5.00K$ 1.45M$ 1.12M$ 1.45M
Currency in USD

InnoCan Pharma Earnings and Revenue History

InnoCan Pharma Debt to Assets

InnoCan Pharma Cash Flow

InnoCan Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis